NASDAQ:NEPH Nephros (NEPH) Stock Price, News & Analysis → Do This Today BEFORE Biden Wins in November (From Stansberry Research) (Ad) Free NEPH Stock Alerts $2.10 -0.11 (-4.98%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$2.06▼$2.2850-Day Range$1.99▼$3.1052-Week Range$1.13▼$4.04Volume10,663 shsAverage Volume14,729 shsMarket Capitalization$22.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Nephros alerts: Email Address Ad Stansberry ResearchDo This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video. About Nephros Stock (NASDAQ:NEPH)Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.Read More NEPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NEPH Stock News HeadlinesMay 9, 2024 | finance.yahoo.comNephros Announces Financial Results for Quarter Ended March 31, 2024May 8, 2024 | americanbankingnews.comNephros (NASDAQ:NEPH) Shares Up 0.5%May 10, 2024 | Stansberry Research (Ad)Do This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).May 2, 2024 | finance.yahoo.comNephros Schedules First Quarter 2024 Financial Results Conference CallMay 1, 2024 | finance.yahoo.comNephros, Inc. (NEPH)April 23, 2024 | finance.yahoo.comNephros to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 20, 2024 | finance.yahoo.comNephros, Inc. (NEPH) Interactive Stock Chart - Yahoo FinanceApril 19, 2024 | finance.yahoo.comNephros, Inc.'s (NASDAQ:NEPH) Profit OutlookMay 10, 2024 | Stansberry Research (Ad)Do This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).March 11, 2024 | finanznachrichten.deNephros, Inc.: Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 10, 2024 | finance.yahoo.comNephros Full Year 2023 Earnings: Misses ExpectationsMarch 9, 2024 | markets.businessinsider.comNephros Poised for Growth: A Buy Recommendation Amid Expansion and Optimized OperationsMarch 9, 2024 | markets.businessinsider.comNephros Poised for Growth: Strong Financials and Strategic Initiatives Secure Buy RatingMarch 8, 2024 | realmoney.thestreet.comNephros just upgraded at Benchmark, here's whyMarch 8, 2024 | finance.yahoo.comNephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | msn.comNEPH Stock Earnings: Nephros Misses EPS, Misses Revenue for Q4 2023March 7, 2024 | globenewswire.comNephros Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 6, 2024 | benzinga.comEarnings Outlook For NephrosMarch 6, 2024 | markets.businessinsider.comNephros earnings: here's what to expectFebruary 29, 2024 | globenewswire.comNephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial ResultsJanuary 28, 2024 | finance.yahoo.comWhat Is Nephros, Inc.'s (NASDAQ:NEPH) Share Price Doing?January 24, 2024 | finanznachrichten.deRezolute, Inc.: Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial OfficerJanuary 24, 2024 | finance.yahoo.comRezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial OfficerDecember 18, 2023 | finance.yahoo.comNephros, Inc.'s (NASDAQ:NEPH) P/S Is Still On The Mark Following 40% Share Price BounceDecember 14, 2023 | morningstar.comNephros Inc NEPHDecember 13, 2023 | finance.yahoo.comAre Investors Undervaluing Nephros, Inc. (NASDAQ:NEPH) By 45%?December 12, 2023 | msn.comNephros CEO buys 18k shares of the company - filingSee More Headlines Receive NEPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/07/2024Today5/10/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NEPH CUSIPN/A CIK1196298 Webwww.nephros.com Phone(201) 343-5202Fax201-343-5207Employees31Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,580,000.00 Net Margins-11.06% Pretax Margin-11.06% Return on Equity-18.25% Return on Assets-14.29% Debt Debt-to-Equity RatioN/A Current Ratio3.98 Quick Ratio2.81 Sales & Book Value Annual Sales$14.24 million Price / Sales1.55 Cash FlowN/A Price / Cash FlowN/A Book Value$0.80 per share Price / Book2.63Miscellaneous Outstanding Shares10,540,000Free Float10,112,000Market Cap$22.13 million OptionableNot Optionable Beta1.24 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Robert Banks (Age 49)President, CEO & Director Comp: $474.04kMs. Judy F. Krandel C.F.A. (Age 59)Chief Financial Officer Comp: $147.01kMr. Alfred VargasDirector of OperationsBrianne McGuireDirector of Brand, Marketing & Business DevelopmentVashone R. ThomasVice President of Quality, Regulatory, & Human ResourcesMr. Daron G. Evans M.B.A. (Age 50)M.S., Chief Executive Officer of Specialty Renal Products, Inc Comp: $300.18kMr. Greg LucasPresident of Aether Water SystemsMs. Judy MazziniControllerMore ExecutivesKey CompetitorsPolyPidNASDAQ:PYPDPAVmedNASDAQ:PAVMLyra TherapeuticsNASDAQ:LYRAMeihua International Medical TechnologiesNASDAQ:MHUAInspira Technologies Oxy B.H.N.NASDAQ:IINNView All CompetitorsInsiders & InstitutionsMesirow Financial Investment Management Inc.Bought 15,383 shares on 4/26/2024Ownership: 0.146%Robert R Jr. BanksBought 18,000 shares on 12/7/2023Total: $39,600.00 ($2.20/share)Robert R Jr. BanksBought 99 shares on 8/14/2023Total: $148.50 ($1.50/share)View All Insider TransactionsView All Institutional Transactions NEPH Stock Analysis - Frequently Asked Questions How have NEPH shares performed in 2024? Nephros' stock was trading at $3.46 at the start of the year. Since then, NEPH shares have decreased by 39.3% and is now trading at $2.10. View the best growth stocks for 2024 here. When is Nephros' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our NEPH earnings forecast. How were Nephros' earnings last quarter? Nephros, Inc. (NASDAQ:NEPH) issued its earnings results on Thursday, March, 7th. The company reported ($0.06) earnings per share for the quarter. The business earned $3.25 million during the quarter. Nephros had a negative trailing twelve-month return on equity of 18.25% and a negative net margin of 11.06%. Who are Nephros' major shareholders? Nephros' stock is owned by a variety of retail and institutional investors. Top institutional investors include Mesirow Financial Investment Management Inc. (0.15%). Insiders that own company stock include Andrew Astor, Robert R Jr Banks, Tom Gwydir and Wesley S Lobo. View institutional ownership trends. How do I buy shares of Nephros? Shares of NEPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NEPH) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlaceGold ManiaStansberry ResearchShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
